ILMN Illumina Inc.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Company profile
Ticker
ILMN
Exchange
Website
CEO
Francis A. deSouza
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
ILLUMINA INC
SEC CIK
Corporate docs
IRS number
330804655
ILMN stock data
()
Calendar
7 Aug 20
25 Sep 20
3 Jan 21
News
Financial summary
| Quarter (USD) | Jun 20 | Mar 20 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Jan 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from Illumina earnings reports.
Recent insider trades
| Date | Owner | Security | Transaction | Code | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|
| 15 Sep 20 | Jay T Flatley | Common Stock | Sell | Dispose S | Yes | 355.22 | 4,000 | 1.42M | 210,933 |
| 9 Sep 20 | Tousi Susan H | Common Stock | Sell | Dispose S | Yes | 350 | 200 | 70K | 45,268 |
| 8 Sep 20 | Tousi Susan H | Common Stock | Sell | Dispose S | Yes | 336 | 100 | 33.6K | 45,468 |
| 1 Sep 20 | Jay T Flatley | Common Stock | Sell | Dispose S | Yes | 355.35 | 4,000 | 1.42M | 214,933 |
| 1 Sep 20 | Charles Dadswell | Common Stock | Sell | Dispose S | Yes | 355.35 | 1,687 | 599.48K | 6,278 |
| 1 Sep 20 | Francis A deSouza | Common Stock | Sell | Dispose S | Yes | 355.8305 | 591 | 210.3K | 71,840 |
| 1 Sep 20 | Francis A deSouza | Common Stock | Sell | Dispose S | Yes | 354.1667 | 300 | 106.25K | 72,431 |
| 1 Sep 20 | Francis A deSouza | Common Stock | Sell | Dispose S | Yes | 353.0067 | 300 | 105.9K | 72,731 |
| 1 Sep 20 | Francis A deSouza | Common Stock | Sell | Dispose S | Yes | 351.759 | 500 | 175.88K | 73,031 |
| 1 Sep 20 | Francis A deSouza | Common Stock | Sell | Dispose S | Yes | 350.7324 | 909 | 318.82K | 73,531 |
Institutional ownership Q2 2020
91.2% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 867 |
| Opened positions | 109 |
| Closed positions | 57 |
| Increased positions | 337 |
| Reduced positions | 288 |
13F shares |
Current |
|---|---|
| Total value | 410.76B |
| Total shares | 133.43M |
| Total puts | 1.37M |
| Total calls | 1.27M |
| Total put/call ratio | 1.1 |
Largest owners |
Shares | Value |
|---|---|---|
| Baillie Gifford & Co | 17.11M | $6.34B |
| Vanguard | 11.71M | $4.34B |
| BLK BlackRock | 11.67M | $4.32B |
| STT State Street | 6.19M | $2.29B |
| Edgewood Management | 5.43M | $2.01B |
| Capital Research Global Investors | 4.01M | $1.49B |
| Sands Capital Management | 3.19M | $1.18B |
| BK Bank of New York Mellon | 3.17M | $1.17B |
| MS Morgan Stanley | 3.08M | $1.14B |
| Capital World Investors | 2.61M | $966.98M |
Financial report summary
?Competition
Thermo Fisher Scientific • BGI • Ceres • Roche Holding • Solexa • Luminex • Biocept • Agilent • Third Wave • CareDx
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Altera, Awarded, certiorari, Commissioner, denied, Description, edge, essential, event, forecasted, freight, frequently, indefinite, intangible, leverage, morale, personnel, petition, President, restated, SamadSenior, staffing, Supreme, travel, Vice, YTD
Removed:
excluded, overturn, prepaid, resolution
Financial reports
10-Q
2020 Q2
Quarterly report
7 Aug 20
10-Q
2020 Q1
Quarterly report
1 May 20
10-K
2019 FY
Annual report
11 Feb 20
10-Q
2019 Q3
Quarterly report
25 Oct 19
10-Q
2019 Q2
Quarterly report
31 Jul 19
10-Q
2019 Q1
Quarterly report
26 Apr 19
10-K
2018 FY
Annual report
12 Feb 19
10-Q
2018 Q3
Quarterly report
23 Oct 18
10-Q
2018 Q2
Quarterly report
31 Jul 18
10-Q
2018 Q1
Quarterly report
25 Apr 18
Current reports
8-K
Entry into a Material Definitive Agreement
21 Sep 20
8-K
Departure of Directors or Certain Officers
21 Aug 20
8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
6 Aug 20
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 20
8-K
Departure of Directors or Certain Officers
12 May 20
8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
30 Apr 20
8-K
Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
14 Apr 20
8-K
Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
6 Feb 20
8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
29 Jan 20
8-K
Results of Operations and Financial Condition
16 Jan 20
Registration and prospectus
425
Business combination disclosure
22 Sep 20
425
Business combination disclosure
22 Sep 20
425
Business combination disclosure
22 Sep 20
425
Business combination disclosure
22 Sep 20
425
Business combination disclosure
21 Sep 20
425
Business combination disclosure
21 Sep 20
425
Business combination disclosure
21 Sep 20
425
Business combination disclosure
21 Sep 20
S-8
Registration of securities for employees
7 Aug 15
S-8
Registration of securities for employees
2 Aug 13
Proxies
DEFA14A
Additional proxy soliciting materials
16 Apr 20
DEF 14A
Definitive proxy
16 Apr 20
DEFA14A
Additional proxy soliciting materials
24 May 19
DEFA14A
Additional proxy soliciting materials
16 Apr 19
DEF 14A
Definitive proxy
16 Apr 19
PRE 14A
Preliminary proxy
25 Mar 19
DFAN14A
Additional proxy materials by non-management
5 Nov 18
DFAN14A
Additional proxy materials by non-management
2 Nov 18
DEF 14A
Definitive proxy
6 Apr 18
DEFA14A
Additional proxy soliciting materials
6 Apr 18
Other
SD
Conflict minerals disclosure
21 May 20
SD
Conflict minerals disclosure
14 May 19
SD
Conflict minerals disclosure
30 May 18
CT ORDER
Confidential treatment order
9 Mar 18
SD
Conflict minerals disclosure
5 Jun 17
NO ACT
No action letter
25 Jan 17
SD
Conflict minerals disclosure
25 May 16
NO ACT
No action letter
18 Mar 16
CT ORDER
Confidential treatment order
24 Aug 15
SD
Conflict minerals disclosure
29 May 15
Ownership
4
ILLUMINA / JAY T FLATLEY ownership change
17 Sep 20
4
ILLUMINA / SUSAN H TOUSI ownership change
10 Sep 20
4
ILLUMINA / Oene Mark Van ownership change
2 Sep 20
4
ILLUMINA / Francis A deSouza ownership change
2 Sep 20
4
ILLUMINA / Charles Dadswell ownership change
2 Sep 20
4
ILLUMINA / JAY T FLATLEY ownership change
2 Sep 20
4
ILLUMINA / ROBERT P RAGUSA ownership change
2 Sep 20
4
ILLUMINA / JAY T FLATLEY ownership change
20 Aug 20
4
ILLUMINA / KAREN K MCGINNIS ownership change
12 Aug 20
4
ILLUMINA / SUSAN H TOUSI ownership change
6 Aug 20
Patents
APP
Utility
Artificial Intelligence-Based Generation of Sequencing Metadata
24 Sep 20
The technology disclosed uses neural networks to determine analyte metadata by (i) processing input image data derived from a sequence of image sets through a neural network and generating an alternative representation of the input image data, the input image data has an array of units that depicts analytes and their surrounding background, (ii) processing the alternative representation through an output layer and generating an output value for each unit in the array, (iii) thresholding output values of the units and classifying a first subset of the units as background units depicting the surrounding background, and (iv) locating peaks in the output values of the units and classifying a second subset of the units as center units containing centers of the analytes.
APP
Utility
Artificial Intelligence-Based Sequencing
24 Sep 20
The technology disclosed processes a first input through a first neural network and produces a first output.
APP
Utility
Training Data Generation for Artificial Intelligence-Based Sequencing
24 Sep 20
The technology disclosed relates to generating ground truth training data to train a neural network-based template generator for cluster metadata determination task.
APP
Utility
Artificial Intelligence-Based Base Calling
24 Sep 20
The technology disclosed processes input data through a neural network and produces an alternative representation of the input data.
GRANT
Reissue
Compensator for multiple surface imaging
22 Sep 20
A system and method for imaging biological samples on multiple surfaces of a support structure are disclosed.